Clinical Trial Update: A Study of the Pharmacokinetics of Testosterone Metered Dose (MD)-Lotion Formulations [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the pharmacokinetics of testosterone metered-dose lotion formulations for hypogonadism has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Testosterone metered-dose lotion (testosterone)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2011-01-07